Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-09-15

Clinical Trial Update: Assessing Bioavailability of CoQ10 Supplementation in Burn Patients [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial assessing how bioavailable Coenzyme Q10 supplementation is in burn injury patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Burn Injury | EARLY_Phase 1 | Status: UNKNOWN